13F Holdings
中文EN

ISRG INTUITIVE SURGICAL INC

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1035267 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY20.5%
TTM net income YoY7.7%
TTM EPS YoY9.4%
Revenue 3-yr CAGR19.1%
Net income 3-yr CAGR24.9%

Margins

Gross margin67.2%
Operating margin28.4%
Net margin25.5%
FCF margin31.1%
EBITDA margin—

Returns

ROE18.0%
ROA15.3%
ROIC (approx.)19.9%
Asset turnover0.60x

Leverage & solvency

Liabilities / assets16.7%
Debt / equity0.00x
Current ratio3.33x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.38x
Accruals ratio-5.9%
Payout ratio—
Capex / revenue4.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$10.06B$8.35B$7.12B$6.22B$5.71B
Cost of revenue$3.42B$2.72B$2.39B$2.03B$1.75B
Gross profit$6.64B$5.63B$4.73B$4.20B$3.96B
R&D expense$1.31B$1.15B$998.80M$879.00M$671.00M
SG&A expense$2.38B$2.14B$1.96B$1.74B$1.47B
Operating income$2.95B$2.35B$1.77B$1.58B$1.82B
Pretax income$3.31B$2.67B$1.96B$1.61B$1.89B
Income tax$434.80M$336.30M$141.60M$262.40M$162.20M
Net income$2.86B$2.32B$1.80B$1.32B$1.70B
EBITDA$3.55B$2.79B$2.15B$1.90B$2.10B
EPS (basic)8.006.545.123.724.79
EPS (diluted)7.876.425.033.654.66
Weighted avg. shares (diluted)362.70M362.00M357.40M362.00M365.80M
Balance sheet
Cash & equivalents$3.37B$2.06B$2.77B$1.60B$1.31B
Short-term investments$2.57B$1.99B$2.47B$2.54B$2.91B
Receivables$1.53B$1.23B$1.13B$942.10M$782.70M
Inventory$1.84B$1.49B$1.22B$893.20M$587.10M
Current assets$9.78B$7.11B$7.89B$6.25B$5.84B
PP&E, net$5.34B$4.65B$3.54B$2.37B$1.88B
Goodwill$370.30M$347.50M$348.70M$348.50M$343.60M
Intangibles$17.10M$23.00M$39.10M$49.80M$70.50M
Total assets$20.46B$18.74B$15.44B$12.97B$13.55B
Current liabilities$2.01B$1.75B$1.66B$1.42B$1.15B
Total liabilities$2.52B$2.21B$2.04B$1.86B$1.60B
Shareholders' equity$17.82B$16.43B$13.31B$11.04B$11.90B
Shares outstanding355.10M356.60M352.30M350.00M357.70M
Cash flow statement
Operating cash flow$3.03B$2.42B$1.81B$1.49B$2.09B
Capital expenditure$539.80M$1.11B$1.06B$532.40M$339.50M
Free cash flow$2.49B$1.30B$749.60M$958.40M$1.75B
Investing cash flow$665.80M-$3.27B-$360.10M$1.37B-$2.46B
Financing cash flow-$2.36B$150.90M-$287.60M-$2.57B$43.00M
Depreciation & amortization$600.00M$439.00M$382.00M$326.00M$280.00M
Stock-based compensation$788.20M$676.80M$592.80M$513.20M$449.20M
Share buybacks$2.30B$0$416.30M$2.61B$0

Free plan shows the latest 5 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.